ASTRO

This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy. 

Proton International and Beaumont Health Open Michigan's First Proton Therapy Facility
News | Proton Therapy | July 17, 2017
July 17, 2017 — Proton International (PI) and Beaumont Health recently opened the state’s first proton therapy center,...
Varian Receives FDA 510k Clearance for Halcyon Treatment System
Technology | Intensity Modulated Radiation Therapy (IMRT) | July 05, 2017
July 5, 2017 — Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the...
Surgery and High-Dose SBRT Radiation Can Be Combined to Treat Kidney Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | July 05, 2017
July 5, 2017 — A new study from Roswell Park Cancer Institute reporting the findings of the first clinical trial to...
First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017
July 3, 2017 — Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health...
IBA and Philips Step Up Commercial Collaboration in Brazilian Proton Therapy Market
News | Radiation Therapy | July 03, 2017
July 3, 2017 — IBA and Philips announced in mid-June they are stepping up their combined effort for proton therapy in...
ASTRO Names 2017 Gold Medalists in Radiation Oncology
News | Radiation Therapy | July 03, 2017
July 3, 2017 — The American Society for Radiation Oncology (ASTRO) announced the 2017 ASTRO Gold Medalists. Søren M....
Multiple Uses for Gamma Knife to Drive Market Growth Through 2025
News | Radiation Therapy | June 29, 2017
June 29, 2017 — Due to its widespread success in treating several types of brain cancer, global market growth for Gamma...
Augmenix Announces First New Zealand Prostate Cancer Patient Treated with SpaceOAR Hydrogel
News | Patient Positioning Radiation Therapy | June 28, 2017
June 28, 2017 — Augmenix Inc. announced that the first patient in New Zealand has been treated with SpaceOAR hydrogel...
ASTRO Issues Guideline for Stereotactic Radiation Use in Early-Stage Lung Cancer
Feature | Lung Imaging | June 23, 2017
June 23, 2017 — The American Society for Radiation Oncology (ASTRO) recently issued a new clinical guideline for the...
University of Wisconsin-Madison Partners With RaySearch on RayCare OIS
News | Oncology Information Management Systems (OIMS) | June 21, 2017
June 21, 2017 — The Department of Human Oncology at the University of Wisconsin-Madison has entered into an agreement...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
June 20, 2017 — Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in...
Henry Ford Cancer Institute First in World to Install Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 19, 2017
June 19, 2017 — The Henry Ford Cancer Institute is the first in Michigan – and first in the world – to offer patients...
stereotactic body radiation therapy (SBRT)
News | Stereotactic Body Radiation Therapy (SBRT) | June 12, 2017
The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline for the use of stereotactic body...
News | Image Guided Radiation Therapy (IGRT) | May 24, 2017
May 24, 2017 — The University Medical Centre (UMC) Utrecht in the Netherlands recently treated the first patient as...
ASTRO's 59th Annual Meeting Will Explore Art and Science of Radiation Oncology
News | Radiation Therapy | May 19, 2017
May 19, 2017 — Registration has opened for the 59th Annual Meeting of the American Society for Radiation Oncology (...
Proton Monte Carlo Dose Calculation Now Part of RayStation Treatment Planning
News | Treatment Planning | May 15, 2017
May 15, 2017 — RaySearch demonstrated a new Monte Carlo dose planning feature for proton therapy on its RayStation...
New Data Presented at ESTRO 36 Demonstrate Various Applications of the CyberKnife System
News | Stereotactic Body Radiation Therapy (SBRT) | May 11, 2017
May 11, 2017 — Accuray Inc. announced that studies on the clinical use of the CyberKnife System continue to demonstrate...
Accuray, CyberKnife system, SBRT, long-term disease control, prostate cancer, ASCO GU study
News | Radiation Therapy | February 17, 2017
February 17, 2017 — Accuray Inc. recently announced data from a prospective, Phase II, 17-center study which showed...
radiotargeted therapy, SST2 antagonists, combat cancer, neuroendocrine tumors, NETs, Journal of Nuclear Medicine study

Comparative receptor autoradiography in various cancer types (A = HE staining) with I-125-JR11 (B+C) and I-125-Tyr3-octreotide (D+E). B and D are the respective total binding, C and E the respective non-specific binding. Bars = 1 mm.

I: Breast cancer. II: Renal cell cancer. III: Medullary thyroid cancer. IV: Non-Hodgkin lymphoma. V: Colon cancer. In cancers I-V, the sections were incubated with 30’000 cpm/100 μl of antagonist or agonist. Cancers I-IV show a much higher density of sst2 with the antagonist. The colon cancer V is negative. VI: Ileal NET, incubated with 10’000 cpm/100 μl of antagonist or agonist. Credit: Jean Claude Reubi, Institute of Pathology, University of Berne, Berne, Switzerland. 

News | Radiation Therapy | February 06, 2017
February 6, 2017 — A study published in the February issue of The Journal of Nuclear Medicine demonstrates the...
Sponsored Content | Videos | Radiation Oncology | January 05, 2017
Join Chris Toth, president, Oncology Systems Americas, for a look at Varian’s new product introductions and major...